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Edited by Sandro SonninoAbstract Cellular phospholipids undergo deacylation and
reacylation through a process known as Lands cycle. In this re-
port, we provide evidence demonstrating that yeast YOR175c,
herein designated as LCA1, encodes a key component of the
Lands cycle, the acyl-CoA: lysophosphatidylcholine acyltrans-
ferase (LPCAT). Deletion of LCA1 resulted in a drastic reduc-
tion in LPCAT activity, while over expression led to a several
fold increase in enzyme activity. We further show that disruption
of LCA1 caused an enhanced production of glycerophosphoryl-
choline, a product of phosphatidylcholine (PC) deacylation and
that the lysophosphatidic acid acyltransferase SLC1 was not in-
volved in this process. Identiﬁcation of LCA1 provides an essen-
tial molecular tool for further study of Lands cycle in PC
turnover.
 2007 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Phosphatidylcholine (PC) serves not only as a major compo-
nent of cellular membranes, but also as a fatty acyl donor for
neutral lipid biosynthesis in eukaryotic organisms and a source
for the production of lipid messengers. There are two meta-
bolic routes through which PC is generated [1]: (i) the Kennedy
cytidine 5 0diphosphocholine (CDP-choline) pathway, where
diacylglycerol (DAG) is a precursor and directly condensed
with CDP-choline; and (ii) a pathway where CDP–DAG is aAbbreviations: PC, Phosphatidylcholine; CDP-choline, cytidine 50-
diphosphocholine; DAG, diacylglycerol; LPCAT, acyl-CoA: lysophos-
phatidylcholine acyltransferase; LPAAT, acyl-CoA: lysophosphatidic
acid acyltransferase; EUROSCARF, European Saccharoymces
cerevisiae archive for functional analysis; DTT, dithiothreitol; PAF,
platelet-activating factor; TCA, trichloroacetic acid; MBOAT, mem-
brane-bound O-acyltransferase; LPA, lysophosphatidic acid; LPC,
lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; LPG,
lysophosphatidylglycerol; LPI, lysophosphatidylinositol; GroPC, glyc-
erophosphorylcholine
q While this manuscript was in preparation, four papers [25–28]
describing the same gene (YOR175c) were published electronically.
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0014-5793/$32.00  2007 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2007.10.061direct precursor, involving phosphatidylserine formation and
decarboxylation and phosphatidylethanolamine methylation.
In the presence of choline, the Kennedy pathway is believed
to be the main route of PC generation in yeast. As a major
phospholipid of eukaryotic cell membrane systems, the level
of PC is maintained by a balance of synthesis and degradation.
An important aspect of PC metabolism ubiquitous in eukary-
otic systems is a process ﬁrst discovered by Lands [2] that con-
cerns the active turnover of the acyl groups in PC. The
eponymous ‘‘Lands Cycle’’ proposes a deacylation–reacylation
process that starts with the deacylation of PC to produce lyso-
phosphatidylcholine (LPC), followed by a reaction that reacy-
lates LPC to PC. The signiﬁcance of this pathway in the
homeostasis of glycerolipids has received a considerable atten-
tion since the deacylation–reacylation process concerns the
remodeling of phospholipid molecules. In animal cells, it has
been shown that this pathway is important for the incorpora-
tion of long chain fatty acids (e.g. arachidonic acid) into PC,
which is released from PC during inﬂammatory responses [3].
The enzymatic components responsible for the deacylation
of PC in yeast have recently been identiﬁed [4,5]. The reacyla-
tion of LPC is mediated by an acyl-CoA: lysophosphatidyl-
choline acyltransferase (LPCAT, E.C. 2.3.1.23). Although
the yeast microsomal LPCAT activity was demonstrated three
decades ago [6,7], the identity of the enzyme remains elusive. A
yeast tafazzin homolog was previously reported as capable of
acylating LPC [8], but this enzyme appeared to be acyl-CoA
independent [9,10]. More recently, a LPCAT involved in pul-
monary surfactant PC production was reported [11,12] in
mammals, but it was not involved in general membrane lipid
synthesis [11]. Here we provide evidence demonstrating that
YOR175c, herein designated as LCA1, possesses LPCAT
activity and plays a pivotal role in PC turnover as a compo-
nent of a lipid remodeling cycle ﬁrst proposed by Lands [2].2. Materials and methods
2.1. Strains and reagents
Yeast strains: BY4741 (WT, MATa hisD1 leuD0 metD0 uraD0),
Y02431 (lca1D, MATa his3D1 leu2D0 met15D0 ura3D 0
YOR175c::KanMX4) and Y03749 (slc1D, MATa his3D1 leu2D0
met15D0 ura3D0 YDL052c::KanMX4) were purchased from European
Saccharoymces Cerevisiae archive for functional analysis (EURO-
SCARF). Various lysophospholipids and acyl-CoAs were obtained
from Avanti Polar Lipids (Alabaster, AL). [14C] oleoyl-CoA, [14C] pal-
mitoyl-CoA, [14C] palmitoyl-LPC were purchased from American
Radiolabeled Chemicals Inc. Yeast extract, Yeast Nitrogen Base, Bac-
to-peptone, and Bacto-agar were purchased from Difco, D-glucose,ation of European Biochemical Societies.
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and plates was prepared according to Invitrogen’s recipe described
for the pYES2.1 TOPO TA Cloning Kit.
2.2. Gene expression vector construction
For TOPO TA-cloning and yeast complementation, Saccharomyces
cerevisiae YOR175c ORF was PCR-ampliﬁed with primers FP:
5 0GGTGATTCTAGACTGCTGCTGATCGCTT3 0 and RP:
5 0GCATCTGTCGTTTTTGGAGCTCTACTCTT30, and cloned into
pYES2.1 vector (Invitrogen). Correctly-oriented plasmids were identi-
ﬁed by DNA sequencing and subsequently introduced into yeast strain
Y02431.
2.3. Microsomal preparation
Yeast strains were ﬁrst grown in 15 ml of SC-leu-his-ura medium
containing 2% glucose. Protein expression induction was carried out
as described in Invitrogen manufacturer manual for yeast expression
vector pYES2.1. After 24 h of growth in SC + 2% galactose + 1% raf-
ﬁnose induction conditions, the cells were washed, ﬁrst with distilled
water and then with wall-breaking buﬀer [50 mM Tris–HCl, 1 mM
EDTA, 0.6 M sorbitol, pH 7.4, 1 mM dithiothreitol (DTT)]. After cen-
trifugation at 4000 rpm (Eppendorf Centrifuge 5145C), the cells were
resuspended in 1 ml wall-breaking buﬀer with 10 ll yeast protease
cocktail (Sigma), and shaken vigorously in the presence of acid-washed
glass beads (diameter 0.5 mm). The resultant homogenate was centri-
fuged at 12000 rpm for 10 min at 4 C. The decanted supernatant
was further centrifuged at 100000 · g for 90–120 min at 4 C. The
supernatant was discarded, and the pellet was suspended in homogeni-
zation buﬀer containing 20% glycerol and frozen at 80 C until use.
Protein concentration was measured using Bio-Rad Protein Assay
Kit for ﬁnal enzyme activity calculation.
2.4. In vitro assay of LPCAT activity
LPCAT substrate speciﬁcity was determined by measuring incorpo-
ration of [14C] LPC or [14C] palmitoyl-CoA into PC. All assays were
performed at least twice. For lysophospholipid substrate speciﬁcity
assessment, 400 ll HEPES buﬀer contained 3 lg microsomal protein,
50 lM of lysophospholipid substrates and 112.5 lM [14C] palmitoyl-
CoA (5.5 nCi/nmol). For acyl-CoA substrate selectivity analysis,
400 ll HEPES reaction buﬀer (pH 7.4, 0.1 M) contained 3 lg micro-
somal protein, 50 lM acyl-CoA and 112.5 lM [14C] palmitoyl-PC
(1.35 nCi/nmol). Reaction was allowed for 2 min at 30 C with
100 rpm shaking. The reaction products were extracted with chloro-
form/methanol (2/1, v/v) and separated with Merck silica G60 TLC
plates. Spots corresponding to diﬀerent phospholipid species products
were scraped oﬀ and 14C incorporation were scintillation counted. Dif-
ferent concentrations of ZnCl2 were added in to reactions for Zn
2+
inhibitory eﬀect assay.
2.5. Lyso-PAF sensitivity
Yeast strains Y02431 over-expressing LCA1 or harboring empty
vector were ﬁrst grown in 15 ml of SC-ura medium containing 2% glu-
cose then transferred to SC-ura + 2% galactose and 1% raﬃnose. After
12 h LCA1 expression induction, the culture was diluted to correspond
to OD600 value of 0.5, 1, 2, 3, 4. Five microliters of each dilution was
spotted to a YPD plate supplemented with varying concentrations of
lyso-platelet-activating factor (PAF). The plates were incubated at
28 C for 2 days.
2.6. PC turnover analysis
PC turnover analysis was performed according to previously de-
scribed method [13] with slight modiﬁcation. Brieﬂy, Y02431 and
BY4741 yeast cells were grown overnight in chemically deﬁned syn-
thetic media without inositol and choline. Yeast at OD600 = 1.5 were
used to inoculate fresh chemically deﬁned synthetic media containing
0.15 lCi/ml [14C] choline chloride (20 lM). Cells were harvested
through centrifugation after 5 h labeling, washed twice in fresh non-
radioactive medium, and then inoculated into in medium containing
10 mM non-radioactive choline. At diﬀerent time points, 1 ml aliquots
were removed and centrifuged. The supernatant was saved as the
‘‘medium’’ fraction. The cell pellet was suspended in 0.5 ml 5% trichlo-
roacetic acid (TCA) and incubated on ice with frequent vortexing. Fol-
lowing centrifugation at 14000 rpm (5414D, Eppendorf), the TCA-
containing supernatant was decanted as ‘‘intracellular water-solublefraction’’, and neutralized by adding 1 M Tris–HCl (pH 8.0) to avoid
acid-induced luminescence in scintillation counting. The pellet was
saved as the ‘‘membrane’’ fraction. The labeling of each fraction was
measured and presented as percentage of total counts in all the three
fractions.
To conﬁrm that the majority of choline-containing compounds in
the TCA fraction were glycerophosphorylcholine (GroPC), the frac-
tions from WT and lca1D yeast cells chased for 2 h at 37 C were ap-
plied to Merck silica G60 gel and developed in a solvent system
containing methanol/0.5% NaCl/NH3 Æ H2O (50/50/1, v/v/v)[14]. After
separation, only one major [14C]-labeled band was detected. This band
was scraped oﬀ, and re-extracted with distilled water to get rid of TCA.
After lyophilization, it is re-applied onto Merck silica G60 plate along
with other choline-containing standards. [14C] choline and [14C] cho-
line containing compound from the TCA fractions were detected with
a scanner (Bioscan Inc.). LPC was stained by iodine exposure, and
other choline-containing standards were visualized by molybdenum
blue spray, a detection reagent speciﬁc for phosphorus in GroPC,
phosphocholine and CDP-choline [15].3. Results and discussion
3.1. Deletion of YOR175cp leads to reduced LPCAT activity
A seminal work by Schuldiner et al. reported a comprehen-
sive genetic-interaction map on the organization of the yeast
early secretory pathway [16]. Several fatty acyltransferase
genes were analyzed in the study, including the previously
identiﬁed sn-2 acyltransferase SLC1. While a negative score
<3 would imply synthetic sick/lethal interaction, the assigned
score for double mutant of slc1 and yor175c was 20 (http://
phoibe.med.utoronto.ca/erg/php/menu.php). This was striking
in light of the fact that residual acyltransferase activity in slc1D
mutant was at a level suﬃcient for balanced cellular growth
[17,18]. A simplest explanation of the exacerbated phenotype
of combined deﬁciency in SLC1 and YOR175c is that
YOR175c is a sn-2 acyltransferase, either like SLC1, a lyso-
phosphatidic acid acyltransferase (LPAAT), or alternatively
another lysophospholipid acyltrasferase. YOR175c does not
exhibit signiﬁcant sequence similarity to other sn-2 acyltrans-
ferases reported to date, but it is a membrane-bound O-acyl-
transferase (MBOAT) family protein [19], and was shown to
be localized in endoplasm reticulum [20]. Members of the
MBOAT family with conﬁrmed functions include diacyglycer-
ol acyltransferase, sterol acyltransferase.
In a preliminary experiment, we ﬁrst examined if disruption
of YOR175c would have any impact on LPAAT and LPCAT
activities using both the parental strain and a slc1D mutant as
controls. Consistent with previous report [17], when lysophos-
phatidic acid (LPA) (18:1) was supplied as acyl acceptor, the
cell lysate of slc1D mutant had a LPAAT level reduced to
63% of the parental strain, but we detected no signiﬁcant
LPAAT reduction in the yor175cD mutant. In marked con-
trast, when LPC was provided as acyl acceptor, our in vitro as-
say showed acyltransferase activity reduction in yor175cD to a
level approximately 28% of the parental strain. The slc1D dis-
played no signiﬁcant decrease in LPCAT activity as compared
with WT strain (Fig. 1).
We further investigated sn-2 lysophospholipid acyltransfer-
ase activity in yor175cD by using microsomal enriched frac-
tions with diﬀerent lysophospholipid acyl acceptors and
palmitoyl-CoA (16:0-CoA). In keeping with the results of total
cell lysate, microsomal fractions of the yor175cD strain showed
a striking decrease in LPCAT activity. Lysophosphatidyletha-
nolamine (LPE) and lysophosphatidylglycerol (LPG) acyl-
LPAAT LPCAT 
0
0.2
0.4
0.6
WT
slc1Δ
lca1Δ
LP
AA
T/
LP
C
AT
 a
ct
iv
ity
 
(n
m
ol
/m
g 
pr
ot
ei
n/
m
in
) 
Fig. 1. Comparison of LPAAT and LPCAT activity of slc1D, lca1D,
and their congenic WT yeast strain. Cell lysates equivalent to 200 lg
protein were assayed for acylation of oleoyl-LPA and oleoyl-LPC with
[14C] oleoyl-CoA. The reaction mixture contained 45 lM 18:1-LPA or
18:1-LPC, 18 lM (10 nCi/nmol) 18:1-CoA. The reaction was to
proceed for 30 min at 30 C with 100 rpm shaking. The results were
presented as a mean of three assays.
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Fig. 3. Lyso-lipid substrate speciﬁcity of LCA1. The assays were
preformed with 3 lg microsomal protein from lca1D harboring an
empty vector (VO) and lca1D expressing LCA1. The reaction
contained 112.5 lM [14C] palmitoyl-CoA (5.5 nCi/nmol) and 50 lM
lysophospholipid substrate (LPA, LPC, LPE, LPG, LPI and LPS).
Reaction was allowed for 2 min with 100 rpm shaking. The results
were presented as a mean of three assays.
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Q. Chen et al. / FEBS Letters 581 (2007) 5511–5516 5513transferase were also slightly decreased, but to a much lesser
degree (Fig. 2). Since LPCAT activity was singularly the most
drastically aﬀected, we thus designate YOR175c as LCA1,
which stands for lysophosphatidylcholine acyltransferase.
3.2. LCA1 displays in vitro acyltransferase activity with
preference for LPC
We next resorted to over-expression to assess the enzyme
properties of LCA1. Microsomal preparations of lca1Dmutant
expressing LCA1 and lca1D harboring the empty vector (VO)
were used to perform acyltransferase assays with [14C] palmi-
toyl-CoA and various lysophospholipids substrates including
LPA, LPC, LPE, LPG, LPI and LPS. As shown in Fig. 3,
the highest activity was found with LPC as substrate. The
activity of LPC acylation was linear at 30 C for 20 min, and
the conversion of LPC to PC is negligible in the absence of
16:0-CoA (data not shown). Over-expression of LCA1 also
caused substantial increases in the acylation of LPG and
LPE. But the rates of LPG and LPE acylation were at a level0
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Fig. 2. Lysophospholipid acyltransferase activity in lca1D, and its
congenic WT yeast strains. Microsomal preparations were assayed for
acylation of palmitoyl-LPA, LPC, LPE, LPG, LPI and LPS with [14C]
palmitoyl-CoA. The reaction mixture contained 45 lM lysophospho-
lipid, 27 lM (10 nCi/nmol) 16:0-CoA and 50 lg protein. The results
were presented as a mean of three assays.approximately 60% and 20%, respectively, of the activity regis-
tered for LPC. Activities for LPA, LPS and LPI, were all less
than 1% of the activity of LPCAT. Thus, LCA1 appeared
capable of accepting several major lysophospholipid classes,
but under our assay conditions it exhibited the highest activity
with LPC. That LCA1 was capable of acylating multiple lyso-
phospholipid molecules was not surprising because substrateLysoPAF
10 µg/ml   
LysoPAF
20 µg/ml  
LysoPAF
LysoPC
10 µg/ml  
LysoPC
20 µg/ml  
LysoPC
Fig. 4. Lyso-PAF and lyso-PC Sensitivity test of lca1D, WT and lca1D
over expressing LCA1. Cells were grown ﬁrst in SC-URA + 2%
glucose media overnight then in protein expression induction media for
6 h. Cultures were diluted to OD600 value of OD600 0.5, 1, 2, 4,
respectively, from which 5 ll was inoculated (from left to right) onto
YPD plate containing lyso-PAF or lyso-PC. The plates were incubated
at 28 C for 36 h.
Table 1
Inhibitory eﬀect of Zn2+ on LCA1 activity
ZnCl2 concentration LPCAT activity (% control)
0 mM (control) 100 ± 7.9
20 mM 6 ± 2.0
0.1 mM 35 ± 22.4
25 lM 149.7 ± 12.0
10 lM 136.8 ± 3.9
5 lM 98 ± 5.9
Results are expressed as means ± S.D. The lca1D over-expressing
LCA1 was used to asses Zn2+ eﬀect. The reactions contained 5.6 lM
palmitoyl-LPC (1.35 nCi/nmol), 1.5 lg microsomal proteins, 0.1 M
HEPES (pH 7.4), 11.25 lM stearyl-CoA and indicated concentration
of ZnCl2. The reaction was stopped after 2 min by adding 2 ml of
chloroform/methanol solution (2:1).
5514 Q. Chen et al. / FEBS Letters 581 (2007) 5511–5516promiscuity has been known for other acyltransferases
[11,21,22].
3.3. Correlation of LCA1 activity with lyso-PAF sensitivity
Although not an endogenous acyl acceptor, ether-linked
glycerolipid, lyso-PAF, can be acylated in yeast, and the reac-
tion was attributed to a LPCAT [7]. When lyso-PAF was used
as acyl acceptor, the lca1D strain had a rate of lyso-PAF acyl-
ation reduced to 31.1% of WT strain. Conversely, over-expres-
sion of LCA1 resulted in 86.3-fold increase in lyso-PAF
acyltransferase activity. It was established previously that high
lyso-PAF level exerts toxic eﬀect on yeast cells [23]. Consistent
with in vitro results, LCA1 mediating lyso-PAF acylation was
also evident in a plate assay (Fig. 4). In our study, both the
parental strain and the lca1D were capable of tolerating LPC
at a level up to 20 lg/ml, but the lca1D mutant displayed
hypersensitivity to lyso-PAF at a concentration above 5 lg/
ml. Moreover, its sensitivity to lyso-PAF was ameliorated by
the expression of LCA1. In contrast, slc1D strain could survive
and grew well on lyso-PAF plate without any apparent diﬀer-
ence from WT cells, indicating SLC1 disruption didn’t aﬀect
lyso-PAF acylation (data not shown). This result thus further
supported the notion that LCA1 is the major LPCAT in yeast.
3.4. Zn2+ inhibitory eﬀect on LPCAT activity
The yeast LPCAT activity was shown to be particularly sen-
sitive to the metal ion Zn2+ while insensitive to Mg2+ [7]. To0
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Fig. 5. Substrate preference assessment of LCA1. A. Acyl-CoA substrate p
lca1D harboring an empty vector (VO) and lca1D expressing LCA1, with
species. B. LPC substrate preference. Assays were preformed with 3 lg micr
lysophospholipid species. The values for lca1D were not shown. The resultsfurther verify that LCA1 represents the dominant contributor
to LPCAT in yeast, we examined whether the LPCAT activity
of LCA1 was aﬀected by addition of Zn2+ in in vitro assays.
Indeed, we found that Zn2+ caused signiﬁcant reduction of
LPCAT activity of LCA1 in a range between 0.1 mM and
20 mM (Table 1). Our results also suggested that a lower
(10-25 lM) concentration of Zn2+ enhanced LPCAT activity.
The maximum increase was observed with 25 lM ZnCl2. We
did not detect signiﬁcant eﬀect of Mg2+ on LPCAT activity
of LCA1, in a concentration ranging from 5 to 40 lM (data
not shown).
3.5. Kinetic parameters of LCA1
The above experiments assessing enzyme properties allowed
us to conclude that LCA1 represented a major LCPAT in
yeast. We next explored the kinetic parameters of this enzyme.
Kinetics constants based on Lineweaver-Burk double-recipro-
cal plot analysis showed that LCA1 had an apparent Km for
acyl-CoA at 0.89 ± 0.25 lM and a Vmax of 524 pmol/min/lg
protein.
LPC molecules are distinguished by fatty acid chain length.
As shown in Fig. 5a, LCA1 exhibited a LPC substrate prefer-
ence in the order of oleic (18:1)-LPC > stearic (18:0)-
LPC > palmitic (16:0)-LPC. The fatty acid substrate speciﬁcity
of the LCA1 was also assessed using acyl-CoA with chain
lengths ranging from 14 to 22 carbons. Based on assays using
50 lM acyl-CoAs, LCA1 could use a broad range of acyl-
CoAs (Fig. 5b), but it displayed particularly high activities
with 16:0-CoA, 18:0-CoA and 18:1-CoA, regardless whether
18:1-LPC or 16:0-LPC was used as acyl acceptor. Interestingly,
LCA1 could also eﬃciently mediate LPC acylation using very
long chain fatty acyl-CoAs, such as 20:0-CoA and 22:6-CoA.
3.6. LCA1 is involved in PC turnover
Since LPCAT is a key component of the classic Lands cycle,
we next studied PC turnover by following an established proto-
col [13]. In this experiment, we included a slc1D strain in the PC
turnover analysis in order to diﬀerentiate the involvement of
SLC1 and LCA1. The yeast cells were cultured and labeled in
chemically deﬁned synthetic medium containing [14C] choline
at 28 C. Because higher growth temperature particularly accel-
erates the deacylation process [13], [14C] choline was subse-0
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reference. Assays were preformed with 3 lg microsomal protein from
112.5 lM [14C] palmitoyl-LPC (1.35 nCi/nmol) and 50 lM acyl-CoA
osomal protein, 112.5 lM [14C] palmitoyl-CoA (5.5 nCi/nmol), 50 lM
were presented as a mean of three assays.
Table 2
Phosphatidylcholine turnover in lca1D, slc1D and BY4741 (WT) strains
28 C 37 C
Chase time (h): 0 1 2 0 1 2
lca1D Medium 12.1 ± 1.7 16.2 ± 1.1 17.4 ± 2.7 12.1 ± 1.7 13.2 ± 3.5 13.3 ± 1.5
Intracellular 41.1 ± 3.2 47.8 ± 2.8 53.6 ± 1.5 41.1 ± 3.2 67.9 ± 2.7 73.5 ± 2.5
Membrane 46.8 ± 2.8 36.0 ± 2.3 28.9 ± 1.5 46.8 ± 2.8 18.9 ± 3.4 13.2 ± 2.3
slc1D Medium 14.5 ± 1.1 16.1 ± 1.3 17.2 ± 1.6 14.5 ± 0.3 18.3 ± 2.3 19.7 ± 0.7
Intracellular 37.4 ± 2.1 40.1 ± 2.2 42.1 ± 3.3 37.4 ± 1.5 49.1 ± 1.9 57.4 ± 4.1
Membrane 48.1 ± 1.7 43.8 ± 2.6 40.7 ± 1.7 48.1 ± 0.9 32.6 ± 2.8 22.9 ± 1.3
WT Medium 14.1 ± 0.8 16.1 ± 2.8 17.1 ± 3.1 14.1 ± 0.8 14.9 ± 1.5 15.3 ± 0.5
Intracellular 36.5 ± 0.2 37.1 ± 1.6 41.6 ± 0.1 36.5 ± 0.2 55.9 ± 2.1 60.7 ± 4.3
Membrane 49.4 ± 0.8 46.9 ± 1.2 41.3 ± 3.2 49.4 ± 0.8 29.2 ± 0.6 24.1 ± 2.7
Yeast cells were labeled at starting OD600 = 1.5 for 5 h in chemically deﬁned synthetic medium containing 0.15 lCi/ml. The cells were then washed
twice, cultured in medium containing 10 mM non-radioactive choline at 28 C and 37 C. One microliter culture aliquot was removed, separated into
three fractions then scintillation counted. The data were presented as mean of three analyses.
Q. Chen et al. / FEBS Letters 581 (2007) 5511–5516 5515quently chased by 10 mM exogenously added choline at 28 C
and 37 C, respectively. The 14C labels in the membrane frac-
tion, intracellular non-membrane fraction, and in the medium
were monitored at diﬀerent time points (Table 2). There was
no signiﬁcant diﬀerence with regard to the dynamics of mem-
brane-associated labels between slc1D andWT. Each lost about
8% at 28 C, and 25% at 37 Cof labeling, in themembrane frac-
tion over the course of 2 h. In contrast, the lca1D strain lost 18%
at 28 C, and 33% at 37 C, over the same period of time. The
label was rising in the intracellular, non-membrane fraction,
which was suggested to be of mainly GroPC [13,24], a product
of PC deacylation. In order to verify the identity of the metab-
olite present in the intracellular fraction, we separated the TCA
fraction through TLC and found that only one [14C]-choline1 2 3 4 5 6 7 
Fig. 6. TLC pattern of choline-containing compounds in the TCA
fraction for PC turnover assessment. Samples were chromatographed
and visualized on Merck Silica Gel G60 plate as described under
Section 2. Lane 1, TCA fraction of WT yeast; lane 2, TCA fraction of
lca1D yeast; lane 3, [14C] choline; lane 4, palmitoleoyl-LPC; lane 5,
GroPC; lane 6, phosphocholine; lane 7, CDP-choline. Dashed line
indicated sample origin.band was present. The metabolite had the same migration rate
as that of GroPC (Fig. 6), thereby conﬁrming that it was indeed
GroPC. Increased GroPC level at both 28 C and 37 C,
suggested that the metabolic impact was independent of PC
deacylation, therefore strongly suggesting that lca1D was com-
promised in the reacylation process of the Lands cycle. That
slc1D had a similar PC turnover rate to that of the WT strain
indicated that, although being a major sn-2 acyltransferase,
SLC1 did not appear to play a signiﬁcant role in PC turnover.4. Conclusions
An earlier report on the interaction of LCA1 and SLC1 led
us to investigate the sn-2 acyltransferase activity of LCA1. The
present study provides several lines of evidence demonstrating
that LCA1 is the hitherto unidentiﬁed LPCAT in yeast. Our
PC turnover experiments reveal that without the participation
of LCA1, the reacylation process of PC is severely crippled.
These results are consistent with the role ascribed for LPCAT
based on the concept of Lands cycle. We propose that LCA1 is
a key enzyme involved in the PC turnover process in yeast.
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